Nisa Investment Advisors
WVE icon

Nisa Investment Advisors’s Wave Life Sciences WVE Stock Holding History

Nisa Investment Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2K Buy
1,814
+506
+39% +$6.59K ﹤0.01% 2144
2025
Q4 		$22.2K Sell
1,308
-268
-17% -$2.72K ﹤0.01% 1903
2025
Q3 		$11.5K Hold
1,576
– – ﹤0.01% 2225
2025
Q2 		$10.2K Buy
1,576
+1,230
+355% +$8.12K ﹤0.01% 2250
2025
Q1 		$2.8K Hold
346
– – ﹤0.01% 2380
2024
Q4 		$4.28K Hold
346
– – ﹤0.01% 2311
2024
Q3 		$2.84K Buy
346
+174
+101% +$1.04K ﹤0.01% 2338
2024
Q2 		$858 Buy
172
+134
+353% +$764 ﹤0.01% 2550
2024
Q1 		$234 Sell
38
-42
-53% -$210 ﹤0.01% 2615
2023
Q4 		$404 Buy
+80
New +$428 ﹤0.01% 2452
2020
Q4 		– Sell
-2,700
Closed -$23K – 2363
2020
Q3 		$23K Buy
+2,700
New +$29.6K ﹤0.01% 2026

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Nisa Investment Advisors's WVE Position: Q1 2026 in Review

Nisa Investment Advisors increased its Wave Life Sciences (WVE) stake by 39% in Q1 2026, buying an estimated $6.59K and bringing the position to 1,814 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2144.

Nisa Investment Advisors first reported a position in WVE in Q3 2020 and has held it in 11 quarters since. The position peaked at $23K in Q3 2020. 231 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Nisa Investment Advisors held 1,814 shares of Wave Life Sciences worth $13.2K as of Q1 2026.
  • Nisa Investment Advisors bought 506 Wave Life Sciences shares in Q1 2026, an estimated $6.59K.
  • Wave Life Sciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2144 holding.
  • Nisa Investment Advisors first reported a position in Wave Life Sciences in Q3 2020 and has held it in 11 quarters since.
  • Nisa Investment Advisors's Wave Life Sciences position peaked at $23K in Q3 2020.
  • 231 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.